L. Oliva et al., THE RESULTS OF STRICTUREPLASTY IN PEDIATRIC-PATIENTS WITH MULTIFOCAL CROHNS-DISEASE, Journal of pediatric gastroenterology and nutrition, 18(3), 1994, pp. 306-310
This study is a retrospective review of eight pediatric patients with
multifocal intestinal Crohn's disease who underwent strictureplasty wi
th or without concomitant bowel resection between January 1978 and Apr
il 1992. The patients ranged in age from 9.9 years to 18.5 years. Indi
cations for surgery were partial intestinal obstruction (n = 6), failu
re of medial therapy or steroid dependence (n = 4), growth failure (n
= 2), and enterocutaneous fistula (n = 2). Thirty-six strictureplastie
s were performed in the eight patients (median, 4.5 strictureplasties
per patient; range, 1-12). Bowel resection was performed in six of the
eight patients in areas where strictureplasty was not feasible. The m
ean length of resection was 40 cm (range, 15-82 cm). The only complica
tion was intestinal hemorrhage, which was conservatively managed in tw
o patients. The patients were followed for a mean of 19 months (range,
3-55 months). Five patients had a weight below the fifth percentile p
rior to surgery. Postoperatively, there was a weight gain in seven pat
ients, including all five patients who were originally below the fifth
percentile. A statistically significant weight gain was found when a
paired t test analysis was applied to the entire group (p = 0.04). Fiv
e of six patients who were on steroid medication at the time of surger
y were successfully weaned within 1.5-3 months (mean, 2.3 months) from
the time of surgery. Seven of eight patients had relief of their inte
stinal symptoms. Strictureplasty with small-bowel resection, or perhap
s strictureplasty alone, in pediatric patients with multifocal intesti
nal Crohn's disease can improve gastrointestinal symptoms, promote wei
ght gain, and allow discontinuation of steroid medications. Stricturep
lasty should be considered for patients who are refractory to medical
therapy or dependent on chronic steroid medication for control of thei
r symptoms.